Etiometry Expands Leadership with New CEO
News and Press Releases
BOSTON, November 7th, 2019 – Etiometry Inc., a leading digital health company which developed a critical care analytics platform, announced today the recent expansion of their leadership team.
Shane Cooke was recently appointed as President and Chief Executive Officer, joining the growing company as it continues to expand its presence in current and new markets. Cooke brings more than 19 years of experience in the medical device and pharmaceutical market spaces in a variety of sales, marketing, strategy, and portfolio management roles. Before joining Etiometry, Cooke spent more than five years as Chief Strategy Officer of Cheetah Medical, which was recently acquired.
“I am excited to join Etiometry, whose best-in-class technology is already utilized in top pediatric hospitals throughout the world” said Cooke. “This technology platform has massive market potential, and I look forward to accelerating growth and realizing the company’s vision of improving outcomes and avoiding patient harm.”
In recent months, Etiometry also expanded their Board of Directors to include Guy Lyndon Fish MD, Gregory S. Martin, CEO and President of Shamrock Holdings, and David Shepherd, co-CEO of Shepherd Kaplan Krochuk.
Former Etiometry CEO and Co-founder, Evan Butler, is taking on a new role as Chief Operating Officer.
About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
HIMSS TV: Etiometry on AI’s role in clinical decision support
In this HIMSS TV interview, Etiometry CEO Shane Cooke dives into the transformative role of AI in clinical decision support—not as a replacement for clinicians, but as a powerful tool to enhance their expertise. Watch the full interview to see how he breaks down how predictive analytics can detect patient deterioration earlier, why AI-driven insights […]
Etiometry Achieves 10th FDA Clearance for Critical Care Platform
FDA Clearance Solidifies Etiometry’s Regulatory Leadership and Cybersecurity Excellence THURSDAY, FEB. 27, 2025- Boston, MA- As cybersecurity threats in healthcare continue to rise, and with the U.S. Food and Drug Administration (FDA) implementing stricter guidelines for cybersecurity compliance, Etiometry, the leader in clinical decision support software for high-acuity units, has received its 10th FDA clearance. This […]
Etiometry Closes the Gap in ARDS/PARDS Detection
In the winter issue of Respiratory Therapy, Jo’el Barr, Clinical Development Specialist at Etiometry, shares insights on the deployment of our PARDS pathway in two top U.S. children’s hospitals. The article highlights how Etiometry’s technology is empowering clinicians to recognize and manage Pediatric ARDS more effectively, driving better outcomes for critically ill children. Read the […]